Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

Millions of Americans take statins to lower their cholesterol, but many still have dangerously high levels of triglycerides and other blood fats that statins don’t address. Now, an experimental pill ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...

An experimental weight loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in the ...

In a letter to European patients, Roche said its decision to end development of “emugrobart” was based on the drug “not ...

Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

A new immunotherapy drug used in a prostate cancer clinical trial is showing early promise in possible treatment of the disease.

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500 ...